Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Sep 30;4(3):334.
doi: 10.4022/jafib.334. eCollection 2011 Sep-Nov.

Cardiac Resynchronization Therapy and Atrial Fibrillation

Ganesh S Kamath  1 , Jonathan S Steinberg  1
Affiliations
Review

Cardiac Resynchronization Therapy and Atrial Fibrillation

Ganesh S Kamath et al. J Atr Fibrillation. .

Abstract

Cardiac resynchronization therapy (CRT) is an important advance for the treatment of end--stage heart failure (HF). About 15-50% of HF is complicated by atrial fibrillation (AF) and associated with worsened outcomes. Meta-analyses from observational studies suggest that patients with AF derive similar benefits to CRT as patients in sinus rhythm (SR). The presence of AF, however, may interfere with optimal delivery of CRT due to competition with biventricular (BiV) capture by conducted beats. Atrioventricular junction (AVJ) ablation with permanent pacing eliminates interference by conducted beats and provides complete BiV capture. Catheter ablation of AF is an alternative to antiarrhythmic drugs to maintain sinus rhythm in patients with AF and HF. Randomized trial comparing catheter ablation, AVJ ablation and pharmacologic therapy are needed.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Kaplan-Meier estimates of the time to the various clinical end-points in patients with atrial fibrillation (AF) and patients in sinus rhythm (SR). HF, Heart failure; MCE, major cardiovascular events. No significant group differences emerged with respect to any of the end-points.
Figure 2
Figure 2. Responders had a higher percentage of fully paced beats than nonresponders (p = 0.03). Nonresponders had a significantly higher percentage of ineffective pacing because of a combination of fusion (p = 0.04) and pseudo-fusion (p = 0.02) beats [Adapted from Kamath et al. J Am Coll Cardiol. 2009; 53: 1050-1055]
Figure 3
Figure 3. Kaplan–Meier estimates of overall (A), cardiac (B), and heart failure (C) survival between AF pts who underwent atrio-ventricular junction ablation (AVJ-abl) and AF patients treated only with negative dromotropic drugs (AF-Drugs) [Adapted from Gasparini et al. Eur Heart J 2008: 29; 1644–1652]with respect to any of the end-points.
Figure 4
Figure 4. Hazard ratio estimates stratified according to cause of death between atrial fibrillation patients who underwent atrio-ventricular junction ablation (AVJ-abl) and patients treated with negative dromotropicdrugs (AF-Drugs) [Adapted from Gasparini et al. Eur Heart J 2008: 29; 1644–1652]
Figure 5
Figure 5. Improvement in left ventricular (LV) function and dimensions after ablation in patients with congestive heart failure [Adapted from Khan et al. N Engl J Med 2004; 359: 1778-1785]
See this image and copyright information in PMC

References

    1. Steinberg Jonathan S. Desperately seeking a randomized clinical trial of resynchronization therapy for patients with heart failure and atrial fibrillation. J. Am. Coll. Cardiol. 2006 Aug 15;48 (4):744–6. - PubMed
    1. Maisel William H, Stevenson Lynne Warner. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am. J. Cardiol. 2003 Mar 20;91 (6A):2D–8D. - PubMed
    1. Calkins Hugh, Brugada Josep, Packer Douglas L, Cappato Riccardo, Chen Shih-Ann, Crijns Harry J G, Damiano Ralph J, Davies D Wyn, Haines David E, Haissaguerre Michel, Iesaka Yoshito, Jackman Warren, Jais Pierre, Kottkamp Hans, Kuck Karl Heinz, Lindsay Bruce D, Marchlinski Francis E, McCarthy Patrick M, Mont J Lluis, Morady Fred, Nademanee Koonlawee, Natale Andrea, Pappone Carlo, Prystowsky Eric, Raviele Antonio, Ruskin Jeremy N, Shemin Richard J. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace. 2007 Jun;9 (6):335–79. - PubMed
    1. Wang Thomas J, Larson Martin G, Levy Daniel, Vasan Ramachandran S, Leip Eric P, Wolf Philip A, D'Agostino Ralph B, Murabito Joanne M, Kannel William B, Benjamin Emelia J. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003 Jun 17;107 (23):2920–5. - PubMed
    1. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood G A, Santini M, Bailleul C, Daubert J C. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N. Engl. J. Med. 2001 Mar 22;344 (12):873–80. - PubMed

LinkOut - more resources